NASDAQ:GHSI
Guardion Health Sciences Inc. Stock News
$7.90
-0.610 (-7.17%)
At Close: May 20, 2024
Nasdaq Grants Guardion Health Sciences an Extension to March 15, 2021 to Regain Compliance with the $1.00 Minimum Bid Price Rule
08:30am, Wednesday, 27'th Jan 2021
SAN DIEGO, Jan. 27, 2021 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (Nasdaq: GHSI) (“Guardion” or the “Company”), a specialty health sciences company that develops clinically supported
GHSI Stock: 11 Things for Investors to Know About Guardion Health Sciences
11:08am, Wednesday, 06'th Jan 2021
Guardion Health Sciences (GHSI) is seeing a massive spike in its stock on Wednesday despite a lack of news concerning the company. The post GHSI Stock: 11 Things for Investors to Know About Guardion H
SAN DIEGO, Dec. 28, 2020 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (Nasdaq: GHSI) (“Guardion” or the “Company”), a specialty health sciences company that develops clinically supported
Guardion Health Sciences Announces Development of New Vision/Energy Support Drink – EPIQ-V
08:00am, Wednesday, 16'th Dec 2020
SAN DIEGO, Dec. 16, 2020 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (Nasdaq: GHSI) (“Guardion” or the “Company”), a specialty health sciences company that develops clinically supported
Guardion Health Sciences Announces Financial Results for the Three Months and Nine Months Ended September 30, 2020
04:05pm, Thursday, 12'th Nov 2020
Guardion A lso Provides Corporate Update
New Study Published on October 26, 2020 in Peer-Reviewed Journal “Nutrients” New Study Published on October 26, 2020 in Peer-Reviewed Journal “Nutrients”
SAN DIEGO, Oct. 27, 2020 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (“Guardion” or the “Company”) (NASDAQ: GHSI) is providing the following answers to frequently asked questions to its
Oct 08, 2020 (The Expresswire) --
Global Contrast Media Market | 2020 Industry Size, Growth, Trends, Share Analysis Report. Global Contrast Media Market Size...
Guardion Health Sciences Reports Results of Operations for Quarter Ended June 30, 2020
08:05pm, Wednesday, 12'th Aug 2020
Asian Nutraceutical Sales Drive Second Quarter RevenuesSAN DIEGO, Aug. 12, 2020 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (“Guardion” or the “Company”) (NASDAQ: GHSI), ), a specialty
Guardion Health Sciences to Report Second Quarter 2020 Financial Results on August 12, 2020
08:05pm, Thursday, 06'th Aug 2020
SAN DIEGO, Aug. 06, 2020 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (Nasdaq: GHSI), a specialty health sciences and nutrition therapy company, today announced it will report financial results
Guardion Health Sciences Adds Experienced Vice President and Chief Financial Officer to Executive Management Team
12:30pm, Tuesday, 21'st Jul 2020
Newly-Appointed CFO Andrew Schmidt BringsExtensive and Wide-Ranging Public Company Experience San Diego, California, July 21, 2020 -- Guardion Health Sciences, Inc..
Guardion Subsidiary VectorVision Receives Approval from Korean Intellectual Property Office for CSV-2000 Trademark
01:00pm, Wednesday, 15'th Jul 2020
The Only Computer Vision Testing Device to Combine Standardized Contrast Sensitivity Testing with a Full Suite of Clinical Vision Tests San Diego, California, July 15, 2020 --.
Guardion Health Sciences Announces Submission of Patent Application for Treatment of Certain Underlying Conditions Related to Eye Disease
12:45pm, Wednesday, 08'th Jul 2020
Guardion Health Sciences, Inc. (“Guardion” or the “Company”) (GHSI), a specialty health sciences company that develops medical foods and medical devices in the ocular health marketplace and wh
Guardion Health Sciences Completes Delivery of $875,000 Order to Malaysian Corporate Customer
09:00am, Tuesday, 30'th Jun 2020
Guardion Health Sciences, Inc. (“Guardion” or the “Company”) (GHSI) announced today that it has completed shipment of Astramern to Astramune Sdn Bhd, a subsidiary of Ho Wah Genting Berhad (“
Anticipating the greatest public health effort of our generation
08:30pm, Thursday, 25'th Jun 2020
Some of the most important lessons learned from past efforts include being willing to pause, evaluate, and adapt if needed.
